Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
Nature Reviews. Urology|July 10, 2010
Kidney cancer: overall survival is an unsuitable primary end pointGiuseppe Di Lorenzo, Carlo BuonerbaEuropean Urology|December 29, 2018
Oligometastatic Prostate Cancer: Is it Only a Matter of Perspective?Giuseppe Di Lorenzo, Carlo BuonerbaExpert Review of Anticancer Therapy|December 21, 2010
Sipuleucel-T for prostate cancer: the immunotherapy era has commencedCarlo Buonerba, Matteo Ferro, Giuseppe Di LorenzoBJU International|December 20, 2011
Sipuleucel-T (Provenge®) for castration-resistant prostate cancerGiuseppe Di Lorenzo, Matteo Ferro, Carlo BuonerbaExpert Review of Molecular Diagnostics|September 27, 2016
Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancerCarlo Buonerba, Giuseppe Di Lorenzo, Guru SonpavdeAnnals of Translational Medicine|April 6, 2016
Combination therapy for metastatic renal cell carcinomaCarlo Buonerba, Giuseppe Di Lorenzo, Guru SonpavdeExpert Review of Anticancer Therapy|February 29, 2012
How to carry out retrospective studies in metastatic renal cell cancer: two caveats that should be avoidedGiuseppe Di Lorenzo, Matteo Ferro, Carlo BuonerbaNature Reviews. Clinical Oncology|May 25, 2011
Immunotherapy for the treatment of prostate cancerGiuseppe Di Lorenzo, Carlo Buonerba, Philip W KantoffAnti-Cancer Drugs|October 24, 2014
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuationGiuseppe Di Lorenzo, Carlo Buonerba, Sabino de PlacidoOncology and Therapy|February 21, 2026
Neoadjuvant Therapy in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer: Recent Progress, Challenges, and Future Directions in the Era of TAR-200 and Enfortumab Vedotin Plus PembrolizumabGiuseppe Di Lorenzo, Massimo Di Maio, Carlo BuonerbaPageof 16